McKesson Corporation Asset Resilience Ratio
McKesson Corporation asset resilience ratio. McKesson Corporation (MCK) has an Asset Resilience Ratio of 3.51% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See McKesson Corporation defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of McKesson Corporation (2000–2025)
Asset resilience ratio of McKesson Corporation from 2000 to 2025. This chart shows how McKesson Corporation's Asset Resilience Ratio has changed over time. Read McKesson Corporation debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down McKesson Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of McKesson Corporation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.96 Billion | 3.51% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $2.96 Billion | 3.51% |
Asset Resilience Insights
- Limited Liquidity: McKesson Corporation maintains only 3.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
McKesson Corporation Industry Peers by Asset Resilience Ratio
Compare McKesson Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Accord Medicines Corp Ltd
SHE:000028 |
Medical Distribution | 0.96% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
TELES Informationstechnologien AG
XETRA:TLIK |
Medical Distribution | 0.37% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
McKesson Corporation Asset Resilience Ratio by Year (2000–2025)
McKesson Corporation asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for McKesson Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 7.57% | $5.69 Billion | $75.14 Billion | +0.78pp |
| 2024-03-31 | 6.80% | $4.58 Billion | $67.44 Billion | -0.71pp |
| 2023-03-31 | 7.51% | $4.68 Billion | $62.32 Billion | +1.88pp |
| 2022-03-31 | 5.63% | $3.56 Billion | $63.30 Billion | -4.03pp |
| 2021-03-31 | 9.66% | $6.28 Billion | $65.02 Billion | +3.10pp |
| 2020-03-31 | 6.56% | $4.01 Billion | $61.25 Billion | +1.56pp |
| 2019-03-31 | 5.00% | $2.98 Billion | $59.67 Billion | +0.57pp |
| 2018-03-31 | 4.43% | $2.67 Billion | $60.38 Billion | -0.14pp |
| 2017-03-31 | 4.56% | $2.78 Billion | $60.97 Billion | -- |
| 2016-03-31 | 0.00% | $0.00 | $56.56 Billion | -- |
| 2015-03-31 | 0.00% | $0.00 | $53.87 Billion | -- |
| 2014-03-31 | 0.00% | $0.00 | $51.76 Billion | -- |
| 2013-03-31 | 0.00% | $0.00 | $34.79 Billion | -- |
| 2012-03-31 | 0.00% | $0.00 | $33.09 Billion | -- |
| 2011-03-31 | 0.00% | $0.00 | $30.89 Billion | -- |
| 2010-03-31 | 0.00% | $0.00 | $28.19 Billion | -- |
| 2007-03-31 | 4.11% | $984.00 Million | $23.94 Billion | -0.48pp |
| 2006-03-31 | 4.59% | $962.00 Million | $20.98 Billion | +4.54pp |
| 2005-03-31 | 0.05% | $9.30 Million | $18.77 Billion | -0.01pp |
| 2004-03-31 | 0.06% | $9.80 Million | $16.24 Billion | -0.02pp |
| 2003-03-31 | 0.08% | $11.50 Million | $14.35 Billion | +0.04pp |
| 2002-03-31 | 0.04% | $5.10 Million | $13.32 Billion | -0.06pp |
| 2001-03-31 | 0.10% | $11.90 Million | $11.53 Billion | -0.45pp |
| 2000-03-31 | 0.55% | $57.00 Million | $10.37 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more